CapsoVision (CV)

CapsoVision’s technology is distinctive because the capsule captures a 360-degree panoramic view and stores images internally, rather than relying on a wearable external data recorder. This approach is intended to improve patient comfort and streamline the procedure for clinics. After the capsule is retrieved, the recorded video can be downloaded and reviewed by healthcare professionals using the company’s software and workflow tools.

The company sells primarily into the United States, where demand is tied to gastroenterology practices, hospitals and diagnostic centers that perform small-bowel imaging. Its growth prospects depend on adoption of capsule endoscopy, reimbursement dynamics, clinical awareness and the strength of its commercial infrastructure. CapsoVision is also developing CapsoColon 3D, a product aimed at imaging the large intestine, which could broaden its addressable market if successfully commercialized.

As a listed medical device company, CapsoVision sits at the intersection of healthcare technology, diagnostics and minimally invasive medicine. Its business is shaped by product performance, regulatory requirements, physician adoption and competition from established endoscopy and imaging companies.